Richard Arlen
About Richard Arlen
Richard Arlen is the Marketing Director Gastroenterology: Innovative Medicines Group at Bristol Myers Squibb, with over 20 years of experience in the pharmaceutical industry. He has held various leadership roles in marketing, medical affairs, and regulatory affairs across multiple therapeutic areas.
Company
Richard Arlen currently works at Bristol Myers Squibb as the Marketing Director for Gastroenterology within the Innovative Medicines Group. He has been with the company in various roles, including Marketing Director for Hematology and Cardiovascular, and Hepatitis C Commercial Lead.
Title
Richard Arlen holds the title of Marketing Director Gastroenterology: Innovative Medicines Group at Bristol Myers Squibb. His role involves leading marketing strategies for innovative treatments in gastroenterology.
Education and Expertise
Richard Arlen has an MBA in Finance from McMaster University, an M.Sc.Phm in Pharmacy from the University of Toronto, and a B.Sc in Toxicology from the University of Guelph. He has over 20 years of experience in the pharmaceutical industry, focusing on therapeutic areas such as gastroenterology, hematology, cardiovascular, and infectious diseases.
Background
Richard's career in pharmaceuticals includes significant roles at Schering-Plough Pharmaceuticals and Novartis, before moving to Bristol Myers Squibb. His positions have encompassed regulatory affairs, medical affairs, brand management, and marketing intelligence, allowing him to gain a comprehensive understanding of both the commercial and medical aspects of the industry.
Achievements
Richard played a crucial role in the commercial success of Hepatitis C treatments at Bristol Myers Squibb. He also developed and implemented marketing intelligence strategies at Novartis, improving the company's market positioning. His work at Schering-Plough Pharmaceuticals in regulatory affairs ensured compliance with industry standards.